Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 218-827-2 | CAS number: 2244-16-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- secondary literature
- Justification for type of information:
- data is from secondary source
Data source
Referenceopen allclose all
- Reference Type:
- secondary source
- Title:
- Scientific Opinion on the safety assessment of carvone, considering all sources of exposure
- Author:
- European Food Safety Authority (EFSA)
- Year:
- 2 014
- Bibliographic source:
- EFSA Journal 2014;12(7):3806
- Reference Type:
- secondary source
- Title:
- Annex 1 Background document to the Opinion proposing harmonised classification and labelling at Community level of carvone
- Author:
- Committee for Risk Assessment RAC -ECHA
- Year:
- 2 013
- Bibliographic source:
- Annex 1 Background document to the Opinion proposing harmonised classification and labelling at Community level of carvone , Committee for Risk Assessment RAC -ECHA ,adopted on 4 June,2013
- Reference Type:
- secondary source
- Title:
- Proposal for Harmonised Classification and Labelling - Carvone
- Author:
- European Chemicals Agency (ECHA)
- Year:
- 2 012
- Bibliographic source:
- Proposal for Harmonised Classification and Labelling – Carvone, European Chemicals Agency (ECHA), 21 September 2012
- Reference Type:
- secondary source
- Title:
- Review report for the active substance carvone
- Author:
- COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL,Standing Committee on the Food Chain and Animal Health
- Year:
- 2 008
- Bibliographic source:
- Review report for the active substance carvone Finalised in the Standing Committee on the Food Chain and Animal Health, in view of the inclusion of carvone in Annex I of Directive 91/414/EEC,22 January 2008
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Principles of method if other than guideline:
- Acute inhalation toxicity study of 2-Methyl-5-(1-methylethenyl)-2-cyclohexenone (99-49-0) in rats according to OECD Guideline 403 (Acute Inhalation Toxicity).
- GLP compliance:
- not specified
- Test type:
- other: no data available
- Limit test:
- no
Test material
- Reference substance name:
- D-p-mentha-1(6),8-dien-2-one
- EC Number:
- 202-759-5
- EC Name:
- D-p-mentha-1(6),8-dien-2-one
- Cas Number:
- 99-49-0
- Molecular formula:
- C10H14O
- IUPAC Name:
- (5R)-2-Methyl-5-prop-1-en-2-ylcyclohex-2-en-1-one
- Test material form:
- liquid
- Details on test material:
- - Name of test material (IUPAC name): 2-Methyl-5-(1-methylethenyl)-2-cyclohexenone- Common name: Carvone- Molecular formula: C10H14O- Molecular weight: 150.2196 g/mol- Smiles notation: CC(=C)C1CC=C(C)C(=O)C1- InChl: 1S/C10H14O/c1-7(2)9-5-4-8(3)10(11)6-9/h4,9H,1,5-6H2,2-3H3- Substance type: Organic- Physical State: Liquid
Constituent 1
- Specific details on test material used for the study:
- - Name of test material (as cited in study report):2-Methyl-5-(1-methylethenyl)-2-cyclohexenone- Molecular formula :C10H14O- Molecular weight :150.2196 g/mol- Substance type:organic
Test animals
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- No data available
Administration / exposure
- Route of administration:
- inhalation
- Type of inhalation exposure:
- not specified
- Vehicle:
- not specified
- Remark on MMAD/GSD:
- No data available
- Details on inhalation exposure:
- No data available
- Remarks on duration:
- No data available
- Concentrations:
- 5.66 mg/l in air (5660 mg/m3)
- No. of animals per sex per dose:
- No data available
- Control animals:
- not specified
- Details on study design:
- Details on study design:- Necropsy of survivors performed: yes- Other examinations performed: clinical signs
- Statistics:
- No data available
Results and discussion
- Preliminary study:
- No data available
Effect levels
- Sex:
- not specified
- Dose descriptor:
- LC50
- Effect level:
- > 5.66 mg/L air
- Based on:
- test mat.
- Remarks on result:
- other: No 50% mortality was observed at dose 5.66 mg/l(5660 mg/m3)
- Mortality:
- One female died the day after the exposure.
- Clinical signs:
- other: During exposure a decreased breathing frequency, and less frequently, post-inspiratory apnoea and superficial breathing were observed.After exposure and increased breathing frequency,post-inspiratory apnoea and dyspnoea were seen. Clinical signs during ex
- Body weight:
- Body weight gain was impaired in most rats during the first week after treatment. Normal body weight gain was observed in the second week, except for two females that showed only marginal body weight gain.
- Gross pathology:
- Gross Pathology revealed no abnormalities, except in the female that died the day after exposure: dark foamy lungs, light coloured liver and air-filled stomach and intestines were observed.
- Other findings:
- No data available
Applicant's summary and conclusion
- Interpretation of results:
- other: not classified
- Conclusions:
- The LC50 value for acute inhalation toxicity test was considered to be >5.66 mg/l in air (5660 mg/m3),when rats were exposed with 2-Methyl-5-(1-methylethenyl)-2-cyclohexenone (99-49-0) by inhalation according to OECD Guideline 403 (Acute Inhalation Toxicity).
- Executive summary:
In acute inhalation toxicity study, rats were exposed to 2-Methyl-5-(1-methylethenyl)-2-cyclohexenone(99-49-0)in the concentration of 5.66 mg/l in air (5660 mg/m3) inhaled as a Single dose. One female died the day after the exposure. During exposure a decreased breathing frequency, and less frequently, post-inspiratory apnoea and superficial breathing were observed. After exposure and increased breathing frequency, post-inspiratory apnoea and dyspnoea were seen. Clinical signs during exposure were restlessness and stress and in coordination and tremors. A dirty and wet fur was observed 24-48h after treatment. Alopecia was observed in a few rats at days 7-13. Body weight gain was impaired in most rats during the first week after treatment. Normal body weight gain was observed in the second week, except for two females that showed only marginal body weight gain.GrossPathology revealed no abnormalities, except in the female that died the day after exposure: dark foamy lungs, light coloured liver and air-filled stomach and intestines were observed.
Therefore, LC50 value was considered to be >5.66 mg/l in air (5660 mg/m3), when rats were exposed with 2-Methyl-5-(1-methylethenyl)-2-cyclohexenone (99-49-0) by inhalation according to OECD Guideline 403 (Acute Inhalation Toxicity).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
